会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • COMPOSITIONS OF LOPINAVIR
    • LOPINAVIR的组成
    • WO2013034926A1
    • 2013-03-14
    • PCT/GB2012/052209
    • 2012-09-07
    • THE UNIVERSITY OF LIVERPOOLGIARDIELLO, Marco NormanMcDONALD, Thomas OliverOWEN, AndrewRANNARD, Steven PaulLONG, JamesMARTIN, Philip JohnSMITH, Darren Lee
    • GIARDIELLO, Marco NormanMcDONALD, Thomas OliverOWEN, AndrewRANNARD, Steven PaulLONG, JamesMARTIN, Philip JohnSMITH, Darren Lee
    • A61K9/19A61K9/51A61K31/536
    • A61K9/1682A61K9/14A61K9/19A61K9/5138A61K31/513A61K45/06
    • The present invention relates to a solid composition and an aqueous dispersion comprising nanoparticles of the anti-retroviral drug lopinavir. The solid composition and aqueous dispersion additionally comprise a mixture of a hydrophilic polymer and a surfactant. The surfactant is selected from vitamin-E-polyethylene glycol-succinate (Vit- E-PEG-succinate), a polyoxyethylene sorbitan fatty acid ester, N- alkyldimethylbenzylammonium chloride, sodium deoxycholate, dioctyl sodium sulfosuccinate, polyethyleneglycol-12-hydroxystearate, polyvinyl alcohol (PVA), and a block copolymer of polyoxyethylene and polyoxypropylene, or a combination thereof. The hydrophilic polymer is suitably selected from polyvinyl alcohol (PVA), a polyvinyl alcohol-polyethylene glycol graft copolymer, a block copolymer of polyoxyethylene and polyoxypropylene, polyethylene glycol, hydroxypropyl methyl cellulose (HPMC), and polyvinylpyrrolidone, or a combination thereof. The present invention also relates to processes for preparing both the solid composition and the aqueous dispersion, as well as to their use in therapy for the treatment and/or prevention of retroviral infections such as human immunodeficiency virus (HIV).
    • 本发明涉及包含抗逆转录病毒药物洛匹那韦的纳米颗粒的固体组合物和水分散体。 固体组合物和水分散体另外包含亲水性聚合物和表面活性剂的混合物。 表面活性剂选自维生素E-聚乙二醇 - 琥珀酸酯(Vit-E-PEG-琥珀酸酯),聚氧乙烯脱水山梨糖醇脂肪酸酯,N-烷基二甲基苄基氯化铵,脱氧胆酸钠,二辛基磺基琥珀酸钠,聚乙二醇-12-羟基硬脂酸酯,聚乙烯醇 (PVA)和聚氧乙烯和聚氧丙烯的嵌段共聚物,或其组合。 亲水性聚合物适当地选自聚乙烯醇(PVA),聚乙烯醇 - 聚乙二醇接枝共聚物,聚氧乙烯和聚氧丙烯的嵌段共聚物,聚乙二醇,羟丙基甲基纤维素(HPMC)和聚乙烯吡咯烷酮或其组合。 本发明还涉及制备固体组合物和水性分散体的方法,以及它们在治疗和/或预防逆转录病毒感染如人类免疫缺陷病毒(HIV)中的用途。
    • 2. 发明申请
    • COMPOSITIONS OF LOPINAVIR AND RITONAVIR
    • LOPINAVIR和RITONAVIR的组合物
    • WO2013034927A8
    • 2013-04-25
    • PCT/GB2012052210
    • 2012-09-07
    • UNIV LIVERPOOLGIARDIELLO MARCO NORMANMCDONALD THOMAS OLIVEROWEN ANDREWRANNARD STEVEN PAULMARTIN PHILIP JOHNSMITH DARREN LEE
    • GIARDIELLO MARCO NORMANMCDONALD THOMAS OLIVEROWEN ANDREWRANNARD STEVEN PAULMARTIN PHILIP JOHNSMITH DARREN LEE
    • A61K9/19A61K9/51A61K31/536
    • A61K31/427A61K9/19A61K9/5138A61K9/5192A61K31/513A61K38/55A61K2300/00
    • The present inventions relates to a solid composition and an aqueous dispersion comprising nanoparticles of the anti-retroviral drugs lopinavir and ritonavir. The solid composition and aqueous dispersion additionally comprise a mixture of a hydrophilic polymer and a surfactant. The surfactant is selected from vitamin-E-polyethylene glycol- succinate (Vit-E-PEG-succinate), a polyoxyethylene sorbitan fatty acid ester, N- alkyldimethylbenzylammonium chloride, sodium deoxycholate, dioctyl sodium sulfosuccinate, polyethyleneglycol-12-hydroxystearate, polyvinyl alcohol (PVA), and a block copolymer of polyoxyethylene and polyoxypropylene, or a combination thereof. The hydrophilic polymer is suitably selected from polyvinyl alcohol (PVA), a polyvinyl alcohol-polyethylene glycol graft copolymer, a block copolymer of polyoxyethylene and polyoxypropylene, polyethylene glycol, hydroxypropyl methyl cellulose (HPMC), and polyvinylpyrrolidone, or a combination thereof. The present invention also relates to processes for preparing both the solid composition and the aqueous dispersion, as well as to their use in therapy for the treatment and/or prevention of retroviral infections such as human immunodeficiency virus (HIV).
    • 本发明涉及包含抗逆转录病毒药物洛匹那韦和利托那韦的纳米颗粒的固体组合物和水分散体。 固体组合物和水性分散体还包含亲水性聚合物和表面活性剂的混合物。 表面活性剂选自维生素E-聚乙二醇 - 琥珀酸酯(Vit-E-PEG-琥珀酸酯),聚氧乙烯脱水山梨醇脂肪酸酯,N-烷基二甲基苄基氯化铵,脱氧胆酸钠,二辛基磺基琥珀酸钠,聚乙二醇-12-羟基硬脂酸酯,聚乙烯醇 (PVA)和聚氧乙烯和聚氧丙烯的嵌段共聚物,或其组合。 亲水性聚合物适当地选自聚乙烯醇(PVA),聚乙烯醇 - 聚乙二醇接枝共聚物,聚氧乙烯和聚氧丙烯的嵌段共聚物,聚乙二醇,羟丙基甲基纤维素(HPMC)和聚乙烯吡咯烷酮,或其组合。 本发明还涉及制备固体组合物和水性分散体的方法,以及它们在治疗和/或预防逆转录病毒感染如人类免疫缺陷病毒(HIV)中的用途。
    • 3. 发明申请
    • COMPOSITIONS OF EFAVIRENZ
    • EFAVIRENZ的组合物
    • WO2013034925A1
    • 2013-03-14
    • PCT/GB2012/052208
    • 2012-09-07
    • THE UNIVERSITY OF LIVERPOOLGIARDIELLO, Marco NormanMcDONALD, Thomas OliverOWEN, AndrewRANNARD, Steven PaulMARTIN, Philip JohnSMITH, Darren Lee
    • GIARDIELLO, Marco NormanMcDONALD, Thomas OliverOWEN, AndrewRANNARD, Steven PaulMARTIN, Philip JohnSMITH, Darren Lee
    • A61K9/51A61K9/10A61K9/19A61K31/536
    • A61K9/14A61K9/10A61K9/1682A61K9/19A61K9/5138A61K9/5192A61K31/536
    • The present inventions relates to a solid composition and an aqueous dispersion comprising nanoparticles of the anti-retroviral drug efavirenz. The solid composition and aqueous dispersion additionally comprise a mixture of a hydrophilic polymer and a surfactant. The surfactant is selected from vitamin-E-polyethylene glycol-succinate (Vit- E-PEG-succinate), a polyoxyethylene sorbitan fatty acid ester, N-alkyldimethylbenzylammonium chloride, sodium deoxycholate, dioctyl sodium sulfosuccinate, polyethyleneglycol-12-hydroxystearate, polyvinyl alcohol (PVA), and a block copolymer of polyoxyethylene and polyoxypropylene, or a combination thereof. The hydrophilic polymer is suitably selected from polyvinyl alcohol (PVA), a polyvinyl alcohol-polyethylene glycol graft copolymer, a block copolymer of polyoxyethylene and polyoxypropylene, polyethylene glycol, hydroxypropyl methyl cellulose (HPMC), and polyvinylpyrrolidone, or a combination thereof. The present invention also relates to processes for preparing both the solid composition and the aqueous dispersion, as well as to their use in therapy for the treatment and/or prevention of retroviral infections such as human immunodeficiency virus (HIV).
    • 本发明涉及包含抗逆转录病毒药物依法韦仑的纳米颗粒的固体组合物和水性分散体。 固体组合物和水性分散体还包含亲水性聚合物和表面活性剂的混合物。 表面活性剂选自维生素E-聚乙二醇 - 琥珀酸酯(Vit-E-PEG-琥珀酸酯),聚氧乙烯脱水山梨糖醇脂肪酸酯,N-烷基二甲基苄基氯化铵,脱氧胆酸钠,二辛基磺基琥珀酸钠,聚乙二醇-12-羟基硬脂酸酯,聚乙烯醇 (PVA)和聚氧乙烯和聚氧丙烯的嵌段共聚物,或其组合。 亲水性聚合物适当地选自聚乙烯醇(PVA),聚乙烯醇 - 聚乙二醇接枝共聚物,聚氧乙烯和聚氧丙烯的嵌段共聚物,聚乙二醇,羟丙基甲基纤维素(HPMC)和聚乙烯吡咯烷酮,或其组合。 本发明还涉及制备固体组合物和水性分散体的方法,以及它们在治疗和/或预防逆转录病毒感染如人类免疫缺陷病毒(HIV)中的用途。